Akoustis Technologies is a commercial company focused on developing, designing, and manufacturing radio frequency (RF) filter products for the wireless industry, including for products such as smartphones and tablets, network infrastructure equipment, WiFi Customer Premise Equipment and defense applications. The company has developed a new and proprietary microelectromechanical systems based bulk acoustic wave technology and manufacturing flow, called XBAW. The company's XBAW? process incorporates high purity piezoelectric materials to achieve high power, high frequency and/or bandwidth filter performance. The company operates in two segments, Foundry Fabrication Services; and RF Filters.

AMREP, through its subsidiaries, is engaged in the real estate business. The company conducts its real estate business primarily in the City of Rio Rancho and certain adjoining areas of Sandoval County, NM. The company sells both developed and undeveloped lots to national, regional and local homebuilders, commercial and industrial property developers and others. The company also acquires land, focusing primarily in New Mexico, after completion of market research, soil tests, environmental studies and other engineering work, a review of zoning and other governmental requirements, discussions with homebuilders or other end-users of the property and financial analysis of the project and estimated development costs.

Arcus Biosciences is a clinical-stage biopharmaceutical company focused on creating cancer immunotherapies. The company has four clinical-stage product candidates: AB928, which is an orally bioavailable, reversible antagonist of the adenosine 2a and adenosine 2b receptors; AB680, which is a reversible and selective inhibitor of the CD73 enzyme; AB122, which is a human antibody with similar binding affinity and other characteristics to the marketed anti-PD-1 antibodies pembrolizumab and nivolumab; and AB154, which is a humanized antibody that inhibits an immune checkpoint target involved in a pathway that plays both inhibitory and stimulatory roles in the immune system.

Paysign is a vertically integrated provider of prepaid card programs and processing services for corporate, consumer and government applications. The company markets its prepaid card solutions under its PaySign brand. The company provides a card processing platform consisting of proprietary systems and software applications. Through its proprietary PaySign platform, the company provides a variety of services including transaction processing, cardholder enrollment, value loading, cardholder account management, reporting, and customer service. The company has developed prepaid card programs for corporate incentive and rewards including, but not limited to, consumer rebates and rewards, and donor compensation.